Skip to main content
glpverdict
Editorial medical reviewFDA & peer-reviewed sourcesUpdated weeklyMedically reviewed content
HomeSwitching guideMounjaro → Zepbound

Medication switch

Switching from Mounjaro to Zepbound

tirzepatide — same active ingredient

Same drug (tirzepatide), Zepbound is the weight-loss-labeled version.

Medically reviewed by Dr. Jane Novak, MD, MPH on May 15, 2026

1 min read

Same active ingredient — straightforward switch

Both Mounjaro and Zepbound contain tirzepatide. Your prescriber typically continues your current dose strength.

Why patients make this switch

  • 1Need weight-management insurance coverage (Zepbound on-label).
  • 2Mounjaro denied or off-label for your indication.
  • 3Want access to LillyDirect self-pay vials (Zepbound only).

Dose transition

Both medications share the same active ingredient. Your prescriber typically continues your current dose strength rather than re-titrating from the starter dose.

Timeline & titration

Continue your current Mounjaro dose strength on Zepbound (2.5, 5, 7.5, 10, 12.5, or 15 mg). Same dose strengths are available across both products.

Side-effect transition

No change expected. Active ingredient and excipients are identical.

Insurance & cost

Zepbound is FDA-approved for chronic weight management — same prior-auth requirements as Wegovy. LillyDirect self-pay vials add a $349–$549/month option not available with Mounjaro.

When this switch is NOT recommended

  • You have type 2 diabetes and Mounjaro is covered — switching to Zepbound may break diabetes claims.
  • You rely on the Mounjaro savings card (Zepbound has a separate program).

Switching to Zepbound? Book a telehealth visit.

Our ranked telehealth providers handle switching prescriptions, prior authorizations, and pharmacy coordination — typically 1–3 business days end to end.

See top providers

Editorial ranking is independent of commission rates.

Frequently asked questions

Is Mounjaro the same as Zepbound?

Yes. Both contain tirzepatide, made by Eli Lilly. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is FDA-approved for chronic weight management and obstructive sleep apnea. The dose strengths (2.5–15 mg) and pen design are identical.

Other switching guides

Reverse direction

Zepbound → Mounjaro

Other from Mounjaro

Mounjaro → Ozempic

Other from Mounjaro

Mounjaro → Wegovy

Other to Zepbound

Wegovy → Zepbound

Other to Zepbound

Ozempic → Zepbound

All 12 switching guides

Keep exploring

Resources for patients moving from Mounjaro to Zepbound.

People also ask

Common questions readers ask

Can you drink alcohol on Wegovy?
No hard contraindication, but alcohol tolerance often drops sharply on GLP-1. Many patients also report reduced desire for alcohol — likely a secondary effect of GLP-1 on the brain reward system.
Full evidence-graded answer
Does GLP-1 affect oral birth control?
Tirzepatide (Mounjaro, Zepbound) has documented reduced absorption of oral contraceptives during the first 4 weeks of each dose increase. Use backup contraception for ~4 weeks after starting + after each step-up. Semaglutide has no documented effect.
Full evidence-graded answer
Can I take GLP-1 while pregnant?
No. All FDA-approved GLP-1s carry a pregnancy contraindication. Stop GLP-1 at least 2 months before planned conception due to its long half-life.
Full evidence-graded answer
Is it safe to take GLP-1 long-term?
Liraglutide has 15+ years of post-marketing data (Victoza approved 2010). Semaglutide has 8+ years (Ozempic approved 2017). No new class-wide safety signals have emerged in extended follow-up. Chronic use is the FDA-approved indication for both T2D and obesity.
Full evidence-graded answer
Do I need to exercise on Wegovy?
Yes — resistance training specifically. Without it, 25-40% of weight lost on GLP-1 comes from lean muscle. Cardio is a bonus; resistance is the non-negotiable.
Full evidence-graded answer